Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1188320130070060725
Gut and Liver
2013 Volume.7 No. 6 p.725 ~ p.730
A Novel, Fully Covered Laser-Cut Nitinol Stent with Antimigration Properties for Nonresectable Distal Malignant Biliary Obstruction: A Multicenter Feasibility Study
Hiroyuki Isayama

Kazumichi Kawakubo
Yousuke Nakai
Kouta Inoue
Chimyon Gon
Saburo Matsubara
Hirofumi Kogure
Yukiko Ito
Takeshi Tsujino
Suguru Mizuno
Tsuyoshi Hamada
Rie Uchino
Koji Miyabayashi
Keisuke Yamamoto
Takashi Sasaki
Natsuyo Yamamoto
Kenji Hirano
Naoki Sasahira
Minoru Tada
Kazuhiko Koike
Abstract
Background/Aims:Stent migration occurs frequently, but the prevention of complications resulting from covered self-expandable metal stents (C-SEMSs) remains unresolved. We prospectively assessed a newly developed C-SEMS, a modified covered Zeo stent (m-CZS), in terms of its antimigration effect.

Methods:Between February 2010 and January 2011, an m-CZS was inserted into 42 patients (31 initial drainage cases and 11 reintervention cases) at a tertiary referral center and three affiliated hospitals. The laser-cut stent was flared for 1.5 cm at both ends, with a 1 cm raised bank located 1 cm in from each flared end. The main outcome of this study was the rate of stent migration, and secondary outcomes were the rate of recurrent biliary obstruction (RBO), the time to RBO, the frequencies of complications, and overall survival.

Results:Of the 31 patients with initial drainage, stent migration occurred in four (12.9%, 95% confidence interval, 5.1% to 29.0%), with a mean time of 131 days. RBO occurred in 18 (58%), with a median time to RBO of 107 days. Following previous C-SEMS migration, seven of 10 patients (70%) did not experience m-CZS migration until death.

Conclusions:m-CZSs with antimigration properties effectively, although not completely, prevented stent migration after stent insertion
KEYWORD
Cholestasis, extrahepatic, Stents, Cholangiography, Endoscopic retrograde
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed